| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/01635581.2016.1180410 |
| P698 | PubMed publication ID | 27266713 |
| P50 | author | Fernando Salvador Moreno | Q59995406 |
| P2093 | author name string | Igor P Pogribny | |
| Renato Heidor | |||
| P2860 | cites work | Cancer genome landscapes | Q22242276 |
| The Polycomb group protein EZH2 directly controls DNA methylation | Q24299020 | ||
| FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1) | Q24338668 | ||
| Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis | Q24535499 | ||
| The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression | Q24608592 | ||
| Downregulation of miR-122 in the rodent and human hepatocellular carcinomas | Q24631076 | ||
| Regulation of chromatin by histone modifications | Q24635070 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice | Q24657152 | ||
| The noncoding RNA revolution-trashing old rules to forge new ones | Q26851952 | ||
| The role of microRNAs in human liver cancers | Q26861699 | ||
| Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma | Q27023524 | ||
| Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition | Q27026986 | ||
| AACR Cancer Progress Report 2014 | Q27346723 | ||
| Global cancer statistics, 2012 | Q27860501 | ||
| Chromatin modifications and their function | Q27861067 | ||
| The Landscape of long noncoding RNA classification | Q28086829 | ||
| Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells | Q28237495 | ||
| Mammalian SIRT1 represses forkhead transcription factors | Q28246430 | ||
| SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells | Q28270360 | ||
| The inhibition by methionine and choline of liver carcinoma formation in male C3H mice dosed with diethylnitrosamine and fed phenobarbital | Q28335836 | ||
| Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells | Q28536197 | ||
| Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 | ||
| Proteome analysis of human hepatocellular carcinoma tissues by two-dimensional difference gel electrophoresis and mass spectrometry. | Q33214400 | ||
| Allyl isothiocyanate as a cancer chemopreventive phytochemical. | Q33622654 | ||
| TET enzymes, TDG and the dynamics of DNA demethylation. | Q33715010 | ||
| Antioxidant defence mechanisms: from the beginning to the end (of the beginning). | Q33750081 | ||
| Cancer chemoprevention: current state of the art | Q33783754 | ||
| Endogenous liver carcinogenesis in the rat. | Q33815859 | ||
| Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications | Q33849214 | ||
| Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo | Q33875921 | ||
| MicroRNAs in liver disease | Q33880442 | ||
| DNA methylation and demethylation in mammals | Q34174778 | ||
| Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. | Q34257246 | ||
| Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancer | Q38093214 | ||
| miR-155: an ancient regulator of the immune system | Q38095500 | ||
| Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections | Q38098807 | ||
| Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis | Q38105832 | ||
| Curcumin as a regulator of epigenetic events | Q38113525 | ||
| The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. | Q38164571 | ||
| Oxidative stress and epigenetic instability in human hepatocarcinogenesis | Q38166561 | ||
| Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma | Q38168041 | ||
| Liver cancer in 2013: Mutational landscape of HCC--the end of the beginning. | Q38176242 | ||
| MicroRNA expression altered by diet: can food be medicinal? | Q38212176 | ||
| The emerging role of microRNAs and nutrition in modulating health and disease | Q38230577 | ||
| Treatment of intermediate-stage hepatocellular carcinoma | Q38236876 | ||
| miR-122--a key factor and therapeutic target in liver disease | Q38259438 | ||
| Alcoholic cirrhosis and hepatocellular carcinoma | Q38271791 | ||
| 5-Methylcytosine DNA glycosylase activity is also present in the human MBD4 (G/T mismatch glycosylase) and in a related avian sequence | Q38307104 | ||
| Impact of Epigenetic Dietary Components on Cancer through Histone Modifications | Q38428453 | ||
| Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma | Q38476457 | ||
| Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. | Q38534459 | ||
| Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling. | Q38869558 | ||
| Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway | Q38919565 | ||
| (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes | Q38952942 | ||
| Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights | Q38962955 | ||
| Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma. | Q38994050 | ||
| Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2. | Q39108639 | ||
| A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma | Q39182952 | ||
| Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling | Q39345427 | ||
| (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus | Q39366534 | ||
| High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma | Q39382114 | ||
| (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry | Q39439105 | ||
| Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells | Q39498483 | ||
| EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. | Q39554903 | ||
| HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients | Q40076803 | ||
| Relationship between folate status and tumour progression in patients with hepatocellular carcinoma | Q40123783 | ||
| GADD45a physically and functionally interacts with TET1 | Q40347085 | ||
| Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. | Q34272080 | ||
| Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients | Q34376920 | ||
| Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis | Q34496914 | ||
| Quantitative research of histone H3 acetylation levels of human hepatocellular carcinoma cells | Q34581453 | ||
| Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine | Q34774406 | ||
| Multi-targeted prevention of cancer by sulforaphane | Q34781826 | ||
| EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers | Q34797908 | ||
| Histone demethylase retinoblastoma binding protein 2 is overexpressed in hepatocellular carcinoma and negatively regulated by hsa-miR-212. | Q34903864 | ||
| Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma | Q34983911 | ||
| Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties | Q34993023 | ||
| Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway | Q35002165 | ||
| miR-155: on the crosstalk between inflammation and cancer | Q35006975 | ||
| Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention | Q35007040 | ||
| Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice | Q35071460 | ||
| Sulforaphane, a cancer chemopreventive agent, induces pathways associated with membrane biosynthesis in response to tissue damage by aflatoxin B1. | Q35077610 | ||
| Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. | Q35084738 | ||
| Chemopreventive strategies in hepatocellular carcinoma | Q35101365 | ||
| Concurrent activation of acetylation and tri-methylation of H3K27 in a subset of hepatocellular carcinoma with aggressive behavior | Q35116342 | ||
| Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs | Q35189998 | ||
| Effects of vitamin B12 and folate deficiencies on DNA methylation and carcinogenesis in rat liver | Q35215615 | ||
| Deletion of betaine-homocysteine S-methyltransferase in mice perturbs choline and 1-carbon metabolism, resulting in fatty liver and hepatocellular carcinomas | Q35379075 | ||
| Gadd45a promotes DNA demethylation through TDG. | Q35562151 | ||
| Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. | Q35609669 | ||
| Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer | Q35803971 | ||
| Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma | Q35945177 | ||
| Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer | Q35977804 | ||
| Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma | Q35995560 | ||
| MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis | Q36129123 | ||
| Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. | Q36129129 | ||
| Evaluation of epigenetic modulation of cyclooxygenase-2 as a prognostic marker for hepatocellular carcinoma | Q36143166 | ||
| Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice | Q36199751 | ||
| Histone deacetylase inhibitors for treatment of hepatocellular carcinoma | Q36237743 | ||
| Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients | Q36450462 | ||
| Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet. | Q36502013 | ||
| Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma | Q36616798 | ||
| Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice | Q36688699 | ||
| Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression | Q36695961 | ||
| Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosis | Q36710902 | ||
| Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD) | Q36766775 | ||
| TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer | Q36777331 | ||
| SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells | Q36907129 | ||
| Keap1 eye on the target: chemoprevention of liver cancer | Q36920757 | ||
| Polymorphisms in 1-carbon metabolism, epigenetics and folate-related pathologies | Q36966016 | ||
| Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine | Q36982678 | ||
| Cancer chemoprevention: a rapidly evolving field. | Q37003415 | ||
| High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions | Q37064910 | ||
| DNA methylation in hepatocellular carcinoma | Q37113559 | ||
| Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. | Q37157400 | ||
| Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma | Q37174094 | ||
| Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases | Q37282734 | ||
| Anti-inflammatory potential of allyl-isothiocyanate--role of Nrf2, NF-(κ) B and microRNA-155. | Q37294637 | ||
| Mammalian cytosine methylation at a glance. | Q37573260 | ||
| Reversing DNA methylation: mechanisms, genomics, and biological functions | Q37609689 | ||
| Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma | Q37632027 | ||
| UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma | Q37632823 | ||
| Curcumin and liver cancer: a review | Q37861767 | ||
| Molecular pathways for cancer chemoprevention by dietary phytochemicals. | Q37866180 | ||
| microRNA involvement in hepatocellular carcinoma | Q37873513 | ||
| Molecular alterations in hepatocarcinogenesis induced by dietary methyl deficiency | Q37957798 | ||
| Cancers with increasing incidence trends in the United States: 1999 through 2008. | Q37979107 | ||
| Cancer chemoprevention and nutriepigenetics: state of the art and future challenges | Q38041440 | ||
| Future directions in cancer prevention | Q38059780 | ||
| Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols | Q40388662 | ||
| Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids | Q40394694 | ||
| Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But | Q40532806 | ||
| Methyl group deficiency in hepatocarcinogenesis | Q40700843 | ||
| Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet | Q40946914 | ||
| (-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis | Q41446435 | ||
| Genetic variations in the one-carbon metabolism pathway genes and susceptibility to hepatocellular carcinoma risk: a case-control study | Q41700141 | ||
| Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway | Q42234880 | ||
| Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid | Q42489252 | ||
| Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine | Q42708200 | ||
| BRCA-1 promoter hypermethylation and silencing induced by the aromatic hydrocarbon receptor-ligand TCDD are prevented by resveratrol in MCF-7 cells | Q42722697 | ||
| Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis | Q43092680 | ||
| Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b | Q43449610 | ||
| Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate | Q43606512 | ||
| Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions | Q44220694 | ||
| Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach | Q44322413 | ||
| Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. | Q44409021 | ||
| Betaine attenuates hepatic steatosis by reducing methylation of the MTTP promoter and elevating genomic methylation in mice fed a high-fat diet | Q44555287 | ||
| Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics | Q44819530 | ||
| Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet | Q44924200 | ||
| A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. | Q45020400 | ||
| Role of DNA damage and alterations in cytosine DNA methylation in rat liver carcinogenesis induced by a methyl-deficient diet. | Q46011976 | ||
| Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. | Q46132555 | ||
| Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis | Q46203147 | ||
| Modulation of hepatic cytochromes P450 and phase II enzymes by dietary doses of sulforaphane in rats: Implications for its chemopreventive activity | Q46500587 | ||
| Disruption of DNA methylation via S-adenosylhomocysteine is a key process in high incidence liver carcinogenesis in fish | Q46636777 | ||
| Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency | Q46689128 | ||
| SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins | Q46809708 | ||
| On the mechanism of demethylation of 5-methylcytosine in DNA. | Q46830714 | ||
| Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane | Q46854767 | ||
| Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats | Q46960395 | ||
| Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice | Q46974887 | ||
| Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma | Q47733432 | ||
| Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. | Q53049522 | ||
| Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition. | Q53218964 | ||
| Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. | Q53219514 | ||
| Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. | Q53232555 | ||
| Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects. | Q53288154 | ||
| Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. | Q53317472 | ||
| Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats. | Q53453110 | ||
| Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. | Q53468823 | ||
| Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma. | Q53516523 | ||
| Inhibitory effects of tea catechins, black tea extract and oolong tea extract on hepatocarcinogenesis in rat. | Q55032510 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| epigenetics | Q26939 | ||
| P304 | page(s) | 719-733 | |
| P577 | publication date | 2016-06-08 | |
| P1433 | published in | Nutrition and Cancer | Q7070508 |
| P1476 | title | Nutritional Epigenetics and the Prevention of Hepatocellular Carcinoma with Bioactive Food Constituents | |
| P478 | volume | 68 |
| Q89977253 | Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma |
| Q60176895 | Curcumin in Liver Diseases: A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective |
| Q64109256 | Dissecting the roles of thymoquinone on the prevention and the treatment of hepatocellular carcinoma: an overview on the current state of knowledge |
| Q47239757 | Quercetin enhances the antitumor effect of trichostatin A and suppresses muscle wasting in tumor-bearing mice |
| Q42281562 | Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling |
| Q59810238 | Targeting Cancer with Phytochemicals via Their Fine Tuning of the Cell Survival Signaling Pathways |
Search more.